Clinical stage | Group A | Group B | Total | P value |
---|---|---|---|---|
Stage I | 3 (6.4%) | 1 (2.5%) | 4 (4.6%) | 0.621 |
Stage II | 10 (21.3%) | 8 (20.0%) | 18 (20.7%) | 0.884 |
Stage IIB | 10 (21.3%) | 5 (12.5%) | 15 (17.3%) | 0.280 |
Stage III | 23 (48.9%) | 26 (65.0%) | 49 (56.3%) | 0.132 |
Stage IIIB | 1 (2.1%) | 0 | 1 (1.1%) | 1.000 |
Total | 47 (100%) | 40 (100%) | 87 (100%) | - |